What Researchers Did
Researchers investigated the effects of a 10-day hyperbaric oxygen therapy on monocyte and lymphocyte function in 30 patients with acute hearing loss.
What They Found
They found that the relative percentages of CD3+, CD4+, CD8+, CD25+, CD14+, and HLA-DR+ cells remained unchanged during and after hyperbaric oxygen therapy. This suggests that repetitive exposure to hyperoxia does not influence human monocyte and lymphocyte functions in this patient group.
What This Means for Canadian Patients
For Canadian patients receiving hyperbaric oxygen therapy, this study suggests that their monocyte and lymphocyte immune cell functions may not be significantly altered. This offers some reassurance regarding the stability of these specific immune cells during such treatment.
Canadian Relevance
There is no direct Canadian connection to this study.
Study Limitations
A limitation is that the study was conducted on a specific patient population with acute hearing loss, which may limit the generalizability of the findings to other patient groups.